SurgePays director buys 40,250 shares at $0.53
SurgePays, Inc. director David Allen May reported open-market purchases of 40,250 shares of common stock at $0.5255 per share.
Rhea-AI Filing Summary
SurgePays, Inc. director David Allen May reported open-market purchases of 40,250 shares of common stock at $0.5255 per share. These buys were executed over three days as part of a single limit order entered on June 3, 2026.
Following the latest purchase, he directly holds 156,626 common shares. A footnote explains that this does not include additional common stock deemed beneficially owned, including 41,750 shares held by XIV LLC, 15,000 shares from prior restricted share awards, and 12,295 shares held by his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 34,716 | $0.5255 | $18K |
| Purchase | Common Stock | 121 | $0.5255 | $63.59 |
| Purchase | Common Stock | 5,413 | $0.5255 | $3K |
Footnotes (1)
- F1. Purchased pursuant to limit order for 40,250 shares at $0.5255 entered June 3, 2026. The Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in column 5 does not include other shares of common stock deemed to be beneficially owned by Mr. May (41,750 shares held in the name of XIV LLC, 15,000 shares issuable pursuant to previous restricted share awards, or 12,295 shares held in the name Mr. May's spouse).
Key Figures
Key Terms
open-market purchase financial
beneficially owned financial
limit order financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SurgePays (SURG) director David Allen May report?
At what price did David Allen May buy SurgePays (SURG) stock?
Does David Allen May have additional beneficial ownership in SurgePays (SURG) beyond direct holdings?
Were David Allen May’s SurgePays (SURG) purchases part of a single order?
AI-generated analysis. How Rhea-AI works. Not financial advice.